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A subpopulation of canine cardiac sarcoplasmic re- 
ticulum vesicles has been found to contain a “Ca2+ 
release channel’’ which mediates the release of intra- 
vesicular Ca2+ stores  with  rates  sufficiently rapid to 
contribute to excitation-contraction coupling in car- 
diac muscle. 45Ca2+ release behavior of passively and 
actively loaded vesicles was determined by Millipore 
filtration and with  the use of a rapid quench apparatus 
using the two Ca2+ channel inhibitors, Mg2+  and ruthe- 
nium red. At  pH 7.0 and 5-20 PM external Ca2+, cardiac 
vesicles released half of their 45Ca2+ stores  within 20 
ms. Ca2+-induced Ca2+ release  was inhibited by raising 
and lowering  external Ca2+ concentration, by the ad- 
dition of Mg2+, and by decreasing the pH.  Calmodulin 
reduced the Ca2+-induced Ca2+ release  rate  3-6-fold in 
a reaction that did not appear to involve a calmodulin- 
dependent protein kinase. Under various experimental 
conditions, ATP or the nonhydrolyzable ATP analog, 
adenosine 5’-(B,y-methylene)triphosphate (AMP- 
PCP), and caffeine stimulated 4SCa2+ release 2-500- 
fold. Maximal release  rates (tU = 10 ms) were observed 
in media containing 10 PM Ca2+ and 5 mM AMP-PCP 
or 10 mM caffeine. An increased external Caz+ concen- 
tration (21 mM) was required to optimize the 45Ca2+ 
efflux rate in the presence of 8 mM Mg2+ and 5 mM 
AMP-PCP. These results suggest that cardiac sarco- 
plasmic reticulum contains a ligand-gated Ca2+ channel 
which is activated by Ca2+, adenine nucleotide, and 
caffeine, and inhibited by Mg2+, H’, and calmodulin. 
Sarcoplasmic reticulum (SR)’ plays an important role in 
the regulation of muscle contraction  and  relaxation by  rapidly 
releasing and  sequestering Ca2+ (for reviews, see Refs. 1-5). 
Physiological  release of Ca2+ from SR is triggered by an  action 
potential  that is thought  to be communicated  to  SR where 
the junctional areas of SR become closely apposed to the 
surface  membrane. How a  surface membrane  action  potential 
induces release of Ca2+ from SR is not well understood. One 
hypothesis,  which is supported by studies with skinned cardiac 
muscle fibers ( 5 ) ,  is the Ca” triggering hypothesis, where Ca“ 
acts as a second messenger. According to this hypothesis, 
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depolarization of the surface membrane allows a few Ca‘+ 
ions to enter the muscle cell, possibly via a Ca2+ channel 
present in the surface membrane.  The Ca2+ which enters  the 
cell diffuses across the gap  between the two membrane  sys- 
tems  and triggers further release of Ca2+ from SR by activating 
the  “Cap+ release channel.” 
Planar lipid bilayer-single channel recording (6) and ion 
flux measurements (7-16) have indicated that “heavy” SR 
vesicles derived from skeletal muscle have a large divalent 
cation selective channel (-100 pS in 50 mM Ca2+) which is 
activated by micromolar concentrations of external  Ca2+, by 
caffeine, and  adenine nucleotides, and  inhibited by M$+, H+, 
calmodulin, and  ruthenium red. In rapid  mixing experiments, 
skeletal SR vesicles released their Ca2+ stores with rates 
similar to  those expected to occur in vivo (12, 14-16). 
In a preliminary  report  (17) we have  shown that  CaZ+ release 
from  isolated  cardiac vesicles occurs through a divalent  cation 
selective ligand-gated channel (-75 pS  in 50 mM Ca2+)  similar 
to  that described  for skeletal SR. To gain further  insight  into 
the regulation of the cardiac channel,  the  present  study fo- 
cuses on  the 45Ca2+  flux  behavior of canine  cardiac SR vesicles 
using  a time scale comparable  with the  excitation-contraction 
cycle in muscle. We report that the cardiac Ca2+ release 
channel, like the  skeletal muscle channel, is activated by Ca2+ 
and  ATP  and  inhibited by Mg2+, H+, and calmodulin, but  that 
there  are significant differences in their sensitivity to  these 
activators  and  inhibitors. 
EXPERIMENTAL PROCEDURES 
Materials-Troponin inhibitor  protein (TnI) was the generous gift 
of Dr. James  Potter (University of Miami Medical School, FL). [3H] 
Ryanodine was kindly provided by Dr. John Sutko (University of 
Texas  Health Sciences Center at  Dallas, TX). “Ca*+ was purchased 
from ICN Pharmaceuticals, Irvine, C A  ruthenium red from Fluka, 
Hauppauge, NY; and  ATP,  the  ATP analog, AMP-PCP,  and calmod- 
ulin from Sigma. All other  materials were of reagent grade. 
Preparation of Membranes-Cardiac muscle SR vesicles were iso- 
lated  from the ventricular  tissue of dogs. Animals were anesthetized 
with  a  sublethal dose of thyamyl (30 mg/kg) followed by removal of 
the  heart via median sternotomy. Excised hearts were immediately 
placed in ice-cold 0.3 M sucrose solution. Muscle was minced and 
homogenized in 7 volumes of 0.3 M sucrose, 1 mM diisopropyl fluo- 
rophosphate, a protease inhibitor, and 20 mM K/Hepes, pH 7.4, at 
4 “C for 60 s in a Waring blender. The homogenate was centrifuged 
for 20 min a t  7,500 rpm (9,200 X g) in a GSA rotor in a  Sorvall RC- 
2 centrifuge. A crude microsomal fraction was obtained from the 
supernatant by centrifugation for 60 min at  33,000 rpm (90,000 X g) 
in Beckman  Type 35 or Ti-45 rotors. The pellets were resuspended 
in approximately  15 ml of 0.3 M sucrose containing 0.4 M KCI, 0.1 
mM MgC12, 100 p M  CaCl,, 100 p M  EGTA, and 5 mM K/Pipes, pH 
6.8, quickly frozen, and stored at -135 “C. 
The crude microsomal fraction was further subfractionated on a 
sucrose gradient as follows. The membranes derived from three dog 
hearts were rapidly thawed and placed in a Beckman Ti-14 zonal 
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rotor on top of a  linear 20-45% (w/w) sucrose gradient containing 
0.4 M KCl, 0.1 mM MgC12, 100 p M  EGTA, 100 p M  CaC12, and 5 mM 
K/Pipes, pH 6.8. After centrifugation for 240 min at  40,000 rpm, 
membranes  sedimenting between 19-25% (Fraction I), 2528% (Frac- 
tion II), 28-31% (Fraction III), 31-34% (Fraction IV), and 34-40% 
(Fraction V) sucrose (as measured with a refractometer at  22 "C) 
were collected, diluted with 1.5 volumes of 0.4 M KC1, and sedimented 
by centrifugation for 60 min at  33,000 rpm in Beckman Type 35 or 
Ti-45 rotors. The pellets were resuspended at  a  protein  concentration 
of 5-10 mg/ml in 0.3 M sucrose, 5 mM K/Pipes, pH 6.8, quickly 
frozen, and stored at  -135 "C before use. 
Heavy rabbit  skeletal muscle SR Ca2+ release vesicle fractions were 
recovered from the 36-45% region of a sucrose gradient that contained 
membranes  sedimenting at  2,600-35,000 X g (13). 
4aCa2+ Flux Measurements with Passively Loaded Vesi~les-'~Ca*+ 
efflux rates from vesicles passively loaded with 45Ca2+ were deter- 
mined with the use of an Update System 1000 Chemical Quench 
apparatus (Madison, WI) and by Millipore filtration (13,  15). Unless 
otherwise indicated, vesicles (2-10 mg of protein/ml) were passively 
loaded for 60 min at  23 "C in a medium containing 1.1 mM 45CaC12, 
100 p M  EGTA, 100 mM KCl, 1 mM diisopropyl fluorophosphate, and 
20 mM K/Pipes, pH 7.0. 45Ca2+ efflux behavior of the vesicles was 
measured by diluting vesicles 5-300-fold into iso-osmotic unlabeled 
release media containing  varying  concentrations of free CaZ+, adenine 
nucleotide, and M e .  In  the rapid quench experiments,  &Ca2+ efflux 
was inhibited at  time  intervals  ranging from 25 to 1000 ms by the 
addition of 10 mM M e ,  5 mM EGTA, and 10 p~ ruthenium red 
(final  concentrations).  Extravesicular 45Ca2+ was separated by placing 
the vesicles on 0.45-p Millipore filters followed  by rapid  rinsing with 
100 mM KC1, 10 mM M$+, 0.1 mM EGTA, 10 FM ruthenium red, 20 
mM K/Pipes, pH 7.0. Radioactivity  retained by the vesicles on the 
filters was determined by liquid scintillation counting. 
4sCaz+ flux measurements were carried out at  least in duplicate 
with two or more time  points.  For  a given preparation the  standard 
errors were +15% or less. 
Incubation of Passively Loaded Vesicles with Calmodulin-Vesicles 
(1 mg of protein/ml) were initially  incubated for 10 min at  23 "C in 
a medium containing 20 mM K/Pipes, pH 7.0, 0.1 M KCl, 100 p M  
Ca2+, 100 p~ EGTA, 1 mM M F ,  10 mM D-glucose, and hexokinase 
(Sigma, 10 units/ml) in order to remove possible small amounts of 
contaminating ATP. After sedimentation and resuspension, vesicles 
(2 mg of protein/ml) were incubated at  23 "C with or without exoge- 
nously added calmodulin or TnI in a medium containing 20 mM K/ 
Pipes,  pH 7.0, 0.12 M KCl, 0.1 mM EGTA, and 0.1 mM 45Ca2c. After 
5 min, the Ca2+  concentration was raised to 1.1 mM and vesicles were 
incubated for an additional 60 min at  23 "C. 
The  amount of ATP remaining in vesicles after  treatment with 
hexokinase was determined by high performance liquid chromatog- 
raphy. Vesicles were sedimented, resuspended, and extracted for 10 
min on ice with 1 N perchloric acid. After removal of the membranes, 
the  extract was neutralized with 5 N K2C0,  and analyzed for ATP 
content on a  SynChropak AX100 column (Linden, IN). 
Skeletal TnI was purified and stored as described by Potter (18). 
dialyzed overnight a t  4 "C against 0.6 M KCl, 100 p M  EGTA, 100 p M  
Prior to the flux studies, TnI (protein concentration 25 gM) was 
Ca2+, and 20 mM K/Pipes,  pH 7. 
45Ca2+ Flux Measurements with Actively Loaded Vesicles-Vesicles 
(25-35 pg of protein/ml) were incubated for 1 min at  23 "C in a 
medium containing 20 mM K/Pipes, pH 7.0,O.l M KC1,lOO pM '%a2+, 
50-600 p~ EGTA, and 8 mM M$+. Uptake media also contained 5 
mM NaN3 and 1.5 p~ carbamyl cyanide N-chlorophenylhydrazone in 
ordar to inhibit possible CaZ+  uptake by contaminating mitochondria. 
%a2+  uptake was initiated by the addition of 5 mM ATP  and was 
determined at  varying time  intervals by placing an aliquot of 0.4 ml 
on a 0.45-p Millipore filter followed by a 10-s rinse with 20 mM K/ 
Pipes, pH 7.0, 0.1 M KC1 medium that  either inhibited  (plus 10 mM 
M e ,  0.1 mM EGTA, and 10 p M  ruthenium  red) or promoted (plus 
100 p~ EGTA and 106 p~ Ca2+, 10 p~ free Ca2+) "Ca2+ efflux from 
Ca2+ release vesicles. Radioactivity retained by actively loaded vesi- 
cles on the filters was determined by liquid scintillation  counting. 
Ca*+ loading rates were determined in media containing 0.1 mM 
45Ca2+, 5 mM MgZ+, 5 mM ATP, and 5 mM oxalate. Vesicles were 
subsequently  rinsed with the channel  inhibiting medium after place- 
ment  onto the filter. 
t'H/Ryanodine Binding-Cardiac vesicles (0.5 mg of protein in 
0.25 ml) were incubated at  37 "C in a medium containing 20 mM K/ 
Pipes, pH 7.0, 0.1 M KC1, 1 mM diisopropyl fluorophosphate, 0.1 mM 
EGTA, 0.1 mM Ca", and [3H]ryanodine (specific activity, 60.8 c i /  
mmol). After 2 and 4 h, an aliquot of the vesicles (0.2 mg  of protein) 
was sedimented by centrifugation for 30 min a t  90,000 X g in a 
Beckman Airfuge. Pellets were briefly washed at  4 "C and radioactiv- 
ity associated with the vesicles and radioactivity remaining in the 
supernatant were determined by liquid scintillation  counting to ob- 
tain bound and free [3H]ryanodine. ['HIRyanodine was added to a 
concentration of 5 nM, greater  concentrations were prepared as  ad- 
mixtures of labeled and unlabeled ryanodine. 
BiochemicalAssays-Protein was determined by the Lowry method 
using bovine serum albumin as a standard. "Basic" and  Me-depend- 
ent, Caz+-stimulated ATPase activities were determined in the pres- 
ence of the ionophore A23187 (2 pg/ml) at  32 "C as previously 
described (13). Free Ca2+ and Mg2+ concentrations were calculated 
according to a  computer program using  binding constants published 
by Fabiato (19); free divalent cation concentrations in  the presence 
of AMP-PCP (15) were estimated using the ATP binding constants 
published by Fabiato. 
RESULTS 
Isolation of Cardiac Ca2+ Release Vesicles-A crude micro- 
somal fraction of canine cardiac muscle was separated  into 
five fractions  on a  sucrose gradient  (Table I). The Ca2+  release 
activities of the five vesicle fractions were determined as 
outlined for Fraction IV in Fig. 1. Vesicles were passively 
loaded with 1 mM 45Ca2+  by incubation for 60 min a t  23 "C 
and then either diluted into a medium which inhibited or 
activated  the Ca2+  release channel of cardiac SR. 45Ca2+ efflux 
was slow when the vesicles were placed into a medium con- 
taining  10 mM Mg2+ and 10 p M  ruthenium  red (Fig. L4). This 
allows one  to  determine  the  amounts of 45Ca2+ (22  nmol/mg 
protein)  trapped by the vesicles in  the  incubation medium. 
When vesicles were diluted  into a  medium which contained 
10 p~ free Ca", about half of this  amount was released in 
less than 30 s. Most of the 45Ca2+ remaining with the vesicles 
in the  10 p~ Ca2+ release  medium was present in a releasable 
form  since  less than 1 nmol of 45Ca2+/mg protein was retained 
when the Ca2+ ionophore A23187 (2 pg/ml) was present. 
Consequently, Fraction IV appeared to be made up of two 
subpopulations of vesicles, only one of which  was capable of 
rapidly  releasing its 45Ca2+ stores  in  the 10 ~ L M  Ca2+ medium. 
Among the five fractions,  the 31-40% sucrose gradient  frac- 
tions  (Fractions IV and V) contained  the highest  percentage 
of vesicles displaying Ca2+ release  activity (Table I). In com- 
parison, the activity of the Ca2+-ATPase, measured in the 
TABLE I 
Enzymatic and Ca2+ release properties of sucrose gradient membrane 
fractions of canine cardiac muscle 
Canine cardiac  membranes were subfractionated into five membra- 
nous  fractions on a sucrose gradient (cf. "Experimental Procedures"). 
Ca2+ release properties of vesicles passively loaded with 1 mM "Ca2+ 
were determined as described in the legend to Fig. 1. The  total  amount 
of "Ca2+ trapped by the vesicles was determined by diluting vesicles 
100-fold into a release medium containing 10 mM M T  plus 10 p M  
ruthenium red. The percent of 45Ca2+ release indicates the portion of 
trapped 45Ca2+ that was rapidly released in the 10 p M  free ca2+ 
medium. Ca2+-ATPase activity was determined as described under 
"Experimental Procedures." The  data  are  the average of five prepa- 
rations f S.E. 
Sucrose gradient  fractions 
______ 
I I1 I11 IV  V 
Density (% sucrose) 19-25  25 8 28-31 31-34 34-40 
Yield (mg protein/ 10 f 2.5 14 k 4 21 f 4 17 f 8 28 k 12 
100 g GLscle) 
(nmol/mg protein) 
45Ca2+in vesicles 2 9 k  6 30 f 5 25 f 4 22 f 4 17 f 4 
Rapid 45Ca2+ release 23 f 16  30 f 9 4 5 f  5 5 5 &  11 50 f 10 
(%) 
mg protein/min) 
Ca"-ATPase (pmol/ 1.8 f 0.2 2.2 f 0.3 1.6 f 0.4 1.3 f 0.3 0.6 f 0.4 
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FIG. 1. Measurement of 4eCa2+ efflux. A ,  cardiac SR vesicles 
(5 mg of protein/ml;  Fraction IV in  Table  I) were passively loaded 
with 1 mM "Caz+ as described under "Experimental Procedures." 
4sCa'+ efflux was initiated by diluting vesicles 100-fold into release 
media containing either 10 mM M e ,  1 mM EGTA plus 10 p M  
ruthenium red (RR)  (0) or 1 mM EGTA  plus 0.95 mM Ca2+ (10 p M  
free Ca" after the addition of the vesicles) (0). 45Ca2+ efflux was 
terminated by placing vesicles on 0.45-p Millipore filters followed by 
rapid rinsing with release medium to remove extravesicular 45Caz+. 
Amounts of '5CaZ+ trapped by all intact vesicles in the incubation 
medium (22 nmol/mg of protein) as well as amounts not readily 
released in  the 10 p~ Ca2+ release  medium (10 nmol/mg of protein) 
were obtained by back extrapolation to  the  time of vesicle dilution. 
B, rapid initial 4sCa2+ efflux rates were determined with the use of an 
Update System 1000 Chemical Quench apparatus (15). Vesicles (2 
mg of protein/ml) passively loaded with 1 mM 4sCa2+ were diluted 
with 4 volumes of release medium containing 0.5 mM EGTA, 0.24 
mM Ca2+ and 0 (0) or 0.875 mM M e  (A).  4sCazf release in the 
presence of 5 mM Mg2+ and 5 mM nucleotide  was  measured by adding 
4 volumes of 10.4 mM M e  plus 11.25 mM AMP-PCP in a second 
mixing step a t  72 ms to 10 p M  Ca", 0.7 mM M e  release medium 
(0). Rapid 4sCa2+ efflux was inhibited at   the indicated  times (50 and 
140 ms in A ;  25-500 ms in B )  by the addition of 4 volumes of a 
quench solution  containing M e ,  EGTA,  and  ruthenium red (final 
concentrations 10 mM, 5 mM and 10 pM, respectively). Vesicles were 
subsequently placed on 0.45-p Millipore filters and rinsed with a 
medium containing 10 mM Mg+,  0.1 mM EGTA,  and 10pM ruthenium 
red. The  amount of  4sCa" remaining  in  the vesicles was determined 
by back extrapolation  to  the  time of addition of the  quench  solution. 
presence of the ionophore A23187, was highest in  the 19-28% 
sucrose gradient  fractions  (Fractions I and 11). 
The  time course of the  rapid release phase  in Fig. lA was 
determined by inhibiting 4sCa2+ efflux at  short  time  intervals 
by the addition of Mg2+ and ruthenium red using a rapid 
quench apparatus (15). In preliminary experiments it was 
found that the cardiac channel was less sensitive  than  the 
skeletal channel to inhibition by Mg2' and ruthenium red. 
Effective inhibition of 45Ca2+ release from cardiac vesicles 
required the presence of both M$+ and  ruthenium red in  the 
quench solution.  Omission of either 10 p~ ruthenium red or 
10 mM Mg2+ from the  channel  inhibiting medium  resulted  in 
incomplete inhibition of rapid 45Ca2+ efflux. Release of more 
than one-half of the 45Ca2+ stores in the Ca2+-permeable 
vesicle population occurred within 30 s, i.e. when the first 
time  point was taken using the Millipore filtration technique. 
In  the presence of adenine nucleotide, an  additional require- 
ment was that  the free Ca2+  concentration was decreased to 
below 1O"j M Ca2+ during  the  quench  step.  This was achieved 
by including in  the  quench  solution  the  Ca2+  chelating  agent 
EGTA. 
Fig. 1A shows that  an appreciable fraction of the rapidly 
releasable  45Ca2+ remained with the vesicles when  45Ca2+ efflux 
was inhibited at 50 and 140 ms by the  addition of the two 
channel  inhibitors, Mg2+ and  ruthenium red. In Fig. lB ,  rapid 
45Caz+ efflux was stopped at  time  intervals ranging from 25 to 
500 ms. In  the 10 p~ Ca2+ medium, the Ca2+  releasing vesicle 
fraction released its %az+ stores  with a half-time of about 25 
ms. 45Ca2+ efflux was slowed about 5-fold by the  addition of 
0.7 mM Mg2+ to  the  10 p~ Ca2+ medium. In  the presence of 
10 p~ ca2+  and 5 mM Mg.AMP-PCP (0.7 mM free M e ) ,  
45Ca2+ was released with a rate comparable to that in the 
Mg+-  and nucleotide-free release medium. Taken together, 
the  data of Fig. 1 suggest that cardiac  sarcoplasmic  reticulum 
vesicles contain a  Ca2+  release channel, which in  the presence 
of micromolar external Ca2+,  mediates the release of Ca2+ with 
rates sufficiently rapid  to  contribute  to  excitation-contraction 
coupling. This  channel  appears  to be inhibited by M$+ and 
activated by adenine nucleotides. 
In Fig. 2, vesicles were passively loaded for varying times 
with 1 mM 45Ca2+.  After incubation of 1 min to 4 h at 23 "C, 
vesicles were diluted into Ca2+ release blocking medium to 
estimate  the  amounts of 45Ca'+ that were accumulated by all 
vesicles. Dilution into the Ca2+ release promoting medium 
was used to  determine  the  fraction of vesicles that lacked the 
Ca2+ release channel. Fig. 2 shows that 45Ca2+ influx was a 
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FIG. 2. Dependence of 4aCa2+ retention by the vesicles on 
incubation time. Cardiac SR vesicles (Fraction IV in  Table  I) were 
incubated for the indicated times with 1 mM "Ca" 
then diluted 200-fold into media containing 10 m M  M P ,  1 mM 
. Vesicles were 
EGTA,  and 10 p~ ruthenium red (RR) (0) or 1 mM EGTA  and 0.97 
mM Ca2+ (10 p~ free CaZ+ after the addition of the vesicles) (0). 
Amounts of 4sCa2+ retained by the vesicles were obtained by back 
extrapolation  to  the  time of vesicle dilution (cf. Fig. l.4). The lower 
curue indicates  the  amount of 4sCa2+ rapidly released in  the  10 p~ 
free Ca2+ medium (0). 
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in  the two uptake curves, i.e. the  amount of 45Ca2+ that was 
released in  the 10 p~ Ca2+ medium,  remained  fairly constant 
with time, suggesting that a similar  number of vesicles con- 
taining viable Ca2+ release channels were present  during  the 
4-h  incubation period. Comparison of the release activity of 
passively and actively loaded vesicles (see below) also sug- 
gested that  the  Ca2+  permeability of the vesicles remained 
largely unaltered during incubation for 1-2 h at  23 "C. In 
other  experiments  it was found  that  the Ca2+ pump mediated 
Ca2+ loading rate of the vesicles (0.5 pmol/mg of protein/min) 
was independent of the  time of vesicle incubation  (not  shown). 
[3H]Ryan~dine  binding  and 45Ca2+ flux measurements have 
indicated  that ryanodine specifically binds  to  the  skeletal  and 
cardiac  SR  Ca2+ release channels (20-22). Cardiac prepara- 
tions have been reported by Pessah  et al. (20) to  bind 0.5 pmol 
of ryanodine/mg of protein  with a KD of 36 nM and 1.7 pmol/ 
mg of protein with a KD of 340 nM. The Ca2+ releasing 
membrane  fractions  obtained  in  this  study  (Fractions IV and 
V of Table I) contained  an appreciably  higher concentration 
of specific high-affinity ryanodine  binding  sites (9 f 3 pmol/ 
mg of protein).  Scatchard  plot  analysis  indicated  the pres nce 
of a single high-affinity  receptor site with  a KO of about 7 nM 
(Fig. 3). Specific high-affinity  [3H]ryanodine  binding  to mem- 
branes displaying a low Ca2+ release activity (Fraction I of 
Table  I)  amounted  to 2-3 pmol/mg of protein  (not  shown). 
Inhibition of 45Ca2+ Release-Ca2+-induced 45Ca2+ release is 
partially inhibited by 1 p~ ruthenium red, 1 pM neomycin, 
and 50 p~ tetracaine (Fig. 4). Preincubation of the vesicles 
with the inhibitors was required to observe the extent of 
inhibition seen in Fig. 4. Without prior exposure, a large 
fraction of the  intravesicular 45Ca2+ was rapidly  released be- 
fore the three compounds were capable of exerting their 
inhibitory effects. 
The effect of varying external M$+ concentration  on 45Ca2+ 
release is shown in Fig. 5. Ca2+-induced  45Ca2+ efflux was half- 
maximally inhibited at  3 X M M e .  In the presence of 
10 mM Mg2+ the tlh of 45Ca2+ release  increased to  about 1 s. 
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FIG. 3. Binding of [3H]ryanodine to cardiac SR vesicles. 
for 2 and 4 h at 37 "C with 1-500 nM [3H]ryanodine as described 
Cardiac SR vesicles (Fraction IV; 2 mg  of protein/ml) were incubated 
under "Experimental Procedures." In the inset, the specific binding 
of [3H]ryanodine is shown in the form of a  Scatchard plot. Specific 
high-affinity binding was obtained by assuming that nonspecific 
binding was linear with ryanodine concentration. Nonspecific binding 
was defined as the difference between total and specific binding and 
amounted to 23.5 pmol/mg of protein at 500 nM [3H]ryanodine. 
Essentially identical amounts of bound and free [3H]ryanodine were 
obtained after incubation for 2 and 4 h at  37 "C. [3H]Ryanodine 
binding to four Caz+ releasing vesicle preparations  (Fraction IV of 
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FIG. 4. Inhibition  of "Ca2+ efflux by  various  drugs. Cardiac 
SR vesicles were passively loaded with 1 mM 4sCa2+ in the absence 
(0, A) or presence of 1 g M  ruthenium red (RR) (O), 1 pM neomycin 
(A), or 50 pM tetracaine (0). After the addition of the vesicles,  release 
media contained 10 p M  free Ca2+ and  the indicated concentrations of 
ruthenium red, neomycin, or tetracaine. 45Ca2+ efflux rates from the 
Ca2+-permeable vesicle population were determined as indicated in 
the legend to Fig. 1. 
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FIG. 5. Dependence  of  the '%a2+ efflux rate on Mg2+ con- 
centration. Cardiac SR vesicles (2 mg  of protein/ml) passively 
loaded with 1 mM 45Ca2+  were diluted into media containing 10 g~ 
free CaZ+  and the indicated concentrations of MgZC. "Ca2+  efflux rates 
from the Ca2+-permeable vesicle population were determined as in- 
dicated in the legend to Fig. 1. 
an  apparent n  value of 1.5 for Mg2+ inhibition of 45Ca2+ release 
(not  shown). A Hill coefficient of 1.5 is in accord with  the 
existence of multiple interacting Mg2+ binding sites. Due to 
the complexity of the system, other explanations cannot, 
however, be  ruled out  at  present. 
Fig. 6 shows that the Ca2+ release behavior of cardiac 
vesicles is affected by calmodulin. In  order  to  establish  that 
calmodulin acted directly on  the  channel  as observed by us 
for skeletal  SR (16) rather  than via a calmodulin-dependent 
protein  kinase  as suggested by Tuana  and  MacLennan  (23), 
vesicles were incubated  with D-glucose,  M$+, and hexokinase, 
sedimented, resuspended in release medium, and extracted 
with perchloric acid. High  performance liquid chromatogra- 
phy analysis of the neutralized extract indicated that the 
amount of ATP  remaining  in  the vesicles was less than  the 
limit of detection (100 pmol/mg of protein). After treatment 
with  hexokinase, vesicles were preincubated with or without 
6 p~ calmodulin and  diluted  into media containing or lacking 
calmodulin. The inset of Fig. 6 shows that exposure of the 
vesicles to calmodulin  increased the tlh of 45Ca2+ efflux from 
about 25 to 150 ms. On a time scale of  30-60 s, similar  amounts 
of 45Ca2+ were released  from vesicles exposed and  not exposed 
to calmodulin. The  similar  extent of release in  the presence 
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FIG. 6. Effect of calmodulin on 46Ca2' release from cardiac 
SR vesicles. Vesicles (2 mg of protein/ml;  Fraction IV in Table I) 
were treated with D-glUCOSe and hexokinase and passively  loaded  with 
1 mM 45Ca2+ in the absence (0, 0) or presence of 6 p M  calmodulin 
(0, .) as described under "Experimental Procedures." After the 
addition of vesicles, release media contained 0 (0, 0) or 1.2 g M  (0, 
.) calmodulin and 5 p M  free ca2+ (0, 0) or 10 mM Me, 1 mM 
EGTA plus 10 p~ ruthenium red (RR) (W, 0). 45Caz+ release rates 
from the Ca'+-permeable vesicle fraction in the 5 p~ Ca2+ release 
medium were determined as indicated in the legend to Fig. 1. 
TABLE I1 
Effects of troponin  inhibitor  protein  and  calmodulin on the Ca2+ 
release behavior of cardiac vesicles 
Cardiac SR vesicles (2 mg/ml; Fraction V of Table I) were treated 
with D-glucose and hexokinase and passively  loaded  with 1 mM 45Ca2+ 
in the presence of the indicated  concentrations of TnI and calmodulin 
as described under "Experimental Procedures." 4sCa2+ efflux rates 
from the Ca2'-permeahle vesicle  population were determined by di- 
luting vesicles &fold into a release medium (10 p M  free Ca2+ after the 
addition of the vesicles) and were  measured  with the use of a rapid 
quench apparatus as indicated in the legend to Fig. 1. 
Additions to vesicle medium 45(la2' efflux 
t*; 
None 25 
1 p M  calmodulin 105 
5 p M  TnI, 1 p M  calmodulin 24 
5 uM TnI 21 
and absence of calmodulin suggested that  the effect of cal- 
modulin was to slow down the release of 45Ca2+  from all  Ca2+ 
release vesicles rather  than  to  inhibit a selected fraction of 
the vesicles. Variation of the calmodulin concentration in 
vesicle and release  media indicated  that  the  Ca2+ release rate 
was half-maximally reduced at 0.1-0.2 p~ calmodulin and 
maximally reduced a t  a  calmodulin concentration of  1-3 p~ 
(not  shown).  For  comparison,  the calmodulin concentration 
of heart  has been estimated  to be 2-3 p~ (24). 
Cardiac vesicles were incubated with the  calmodulin-bind- 
ing  component of Tn12 to assess  possible inhibition of 45Ca2+ 
release by an  impurity  present  in  the commercial preparation 
of calmodulin or by endogenous  calmodulin. Table I1 shows 
J. Potter, personal communication. 
that  TnI was effective in  neutralizing  the  inhibitory effect of 
1 p~ calmodulin  in that  it  maintained  the release rate  at a 
value  seen in  the absence of added calmodulin. Inhibition of 
the  channel by another  component  present in the calmodulin 
preparation  appears  therefore  to be unlikely. In  the absence 
of added calmodulin, TnI increased the release rate of cardiac 
vesicles by about  15%.  This  result raises the possibility that 
isolated cardiac vesicles contain small amounts of calmodulin 
which inhibit  the  channel. 
pH Dependence of 45Ca2+ Release and Exchange-The pH 
dependence of 45Ca2+ efflux from  cardiac vesicles was meas- 
ured in  a  medium containing 5 p~ or 1 mM free  Ca2+  (Fig. 7). 
In  the presence of a  maximally activating  Ca2+  concentration 
of 5 p~ (see below), vesicles released half their 45Ca2+ within 
20 ms at  pH 7.0. At pH 6.0, 45Ca2+ release was about 50-fold 
reduced, occurring with a half-time of 1 s. Cardiac vesicles 
were equilibrated  with 1 mM 45Ca2+ by incubating for 1 h (Fig. 
2). An increase in  external  Ca2+  concentration  to 1 mM in  the 
release medium therefore allowed measurement of the  Ca2+ 
release  behavior of the vesicles under 4sCa2+-40Ca2+  exchange 
conditions.  Calcium  exchange proceeded with  about a  &fold 
lower rate than 45Ca2+ release at pH values below 7. The 
calcium exchange rate steadily increased from pH 6 to 8, 
without  appearing  to  reach a  maximal  value at  pH 8. 
Activation of 45Ca2' Release by ea2+, Nucleotides, and Caf- 
feine-The 'Ta2+ release  behavior of canine  cardiac vesicles 
has been studied  in  the presence of Ca2+,  ATP  (AMP-PCP), 
and caffeine, and compared with  the release  behavior of rabbit 
skeletal muscle SR Ca2+ release vesicles (Table 111). At pH 
7.0 in 10-~ M free Ca2+, 45Ca2+ release was slow, requiring  a tJh 
of 25 and 8 s for cardiac and  skeletal vesicles, respectively. 
An increase in free  Ca2+ to 2 p~ and  addition of the  nonhy- 
drolyzable ATP  analog  AMP-PCP increased the release rate 
by a  factor of about 1000 in  both  preparations.  In  the pr sence 
of micromolar  Ca2+ and millimolar  nucleotide,  nearly optimal 
release rates were observed since the cardiac and skeletal 
channels  are ssentially open all the  time,  as shown previously 
in single channel  measurements (6, 17).  Intermediate release 
rates were obtained when the two channels were activated at  
lo-' M Ca2+ by either  ATP or caffeine or by M Ca2+ alone. 
I .  t I .; 
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FIG. 7. Dependence of the 4sCa2+ efflux rate on pH. Cardiac 
SR vesicles (Fraction V in  Table I) were  passively  loaded with 1 mM 
45Ca2+ by incubating vesicles for 60 min at 23 "C in a medium 
containing 0.1 M KC1 and either 20 mM K/Pipes (pH 6.0-7.0) or 20 
mM K/Hepes  (pH 7.0-8.0). Vesicles  were diluted into media contain- 
ing 5 p~ (0) or 1 mM free (0) Ca2+, after the addition of the vesicles. 
*'CaZ+ efflux rates from the Ca2+-permeable vesicle fraction were 
determined as described in the legend to Fig. 1. 
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TABLE I11 
Activation of  "Ca" release from cardiac and skeletal muscle SR 
vesicles by Ca2+, adenine nucleotide, and caffeine 
"Ca2+ efflux rates were determined as described in  the legend to 
Fig. 1. "Ca2+ release at  2 X lo-' M CaZ+ was determined by initially 
lowering the free Cazf  concentration to 4 x lo-' M (15) before adding 
ATP  or caffeine in a second mixing step. Vesicles released half their 
"Ca2+ stores within the indicated  times. 
Additions t o  release medium 
"Ca2+ efflux 
, Cardiac  Skeletal 
t*; s 
2 x io-' M Ca2+ 25 8 
2 X IO-' M Ca2+, 5 mM ATP 12 0.06 
2 X io-' M Ca2+, 10 mM caffeine 0.05 0.4 
io-' M Ca2+ 0.02 0.6 
2 X M Ca2+, 5 mM AMP-PCP 0.01 0.01 
io+ M Ca2+, 10 mM caffeine 0.01 0.5 
Several important differences were noted  to  exist between 
cardiac  and  skeletal SR. At M external Ca2+, the tt,$ of 
45Ca2+ release was 20 ms for cardiac vesicles, as  compared  to 
600 ms for skeletal vesicles. Caffeine  mimicked the effects of 
external Ca2+ in that it was more effective in stimulating 
45Ca2+  release  from cardiac  than  skeletal vesicles in the low 
Ca2+ medium.  At  micromolar Ca", 10 mM caffeine, like 5 mM 
nucleotide, optimally stimulated 45Ca2+ efflux from cardiac 
vesicles, whereas in  skeletal vesicles it was without a  signifi- 
cant effect. In  contrast,  adenine nucleotides were more effec- 
tive in stimulating 45Ca2+ release  from skeletal  than  cardiac 
vesicles. Addition of 5 mM ATP  to  the lo-' M Ca2+ medium 
increased 45Ca2+ efflux 100-fold from skeletal vesicles, as 
compared  to  an only %fold increase  from  cardiac vesicles. 
Addition of other  trinucleotides (5 mM CTP,  GTP,  ITP, or 
UTP)  to  the lo-' M Ca2+  medium was without  an appreciable 
effect on  ca2+ release  from cardiac vesicles. Similarly, 5 pM 
inositol 1,4,5-triphosphate,  another  potential  activator f the 
Ca2+ release channel (25-27), did not increase 45Ca2+ efflux 
when  added to  the lo-' M Ca2+  release  medium (not  shown). 
Ca2+ Dependence of Ca2+ Release-We have attempted  to 
mimic the ionic conditions  in relaxed and  contracted muscle 
by determining the Caz+ dependence of Ca2+ release from 
cardiac vesicles in  the presence and absence of  Mg2+ and  the 
nonhydrolyzable ATP analog AMP-PCP. Canine myocar- 
dium contains  about 5 mM ATP (28). The free Mg2+ concen- 
tration of cardiac muscle is not known but  has been estimated 
to  range from about 0.2 to 4 mM in  skeletal muscle (29, 30). 
In  the absence of Mg2+ and nucleotide,  a  maximal  release rate 
was  measured in media containing  about 5-20 p~ free  Ca2+ 
(Fig. 8). 45Ca2+ release was slow at nanomolar Ca2+ and was 
severalfold reduced at  millimolar concentrations of Ca2+. Ef- 
fects of external Ca2+ on 45Ca2+ efflux in Fig. 8 can be most 
easily  explained by assuming  that  the  channel possesses ac- 
tivating  and  inhibitory Ca2+ binding sites. 
Adenine  nucleotide modified Ca2+-induced Ca2+  release 
from  cardiac SR in two ways. One effect of AMP-PCP was to 
increase the maximally  observable  Ca2+  release rate.  In Fig. 
8, the t,,+ of 45Ca2+ release was decreased  from about 25 to  15 
ms by 5 mM AMP-PCP. A  second  effect of AMP-PCP was to 
shift  the Ca2+ activating curve to  the  left by lowering the half- 
maximally activating Ca2+ concentration from about 2 x 10"j 
M to 8 X M. Variation of AMP-PCP concentration a t  3 
x M Ca2+ indicated that a high concentration of nucleo- 
tide (5-10 mM range) was required to optimally stimulate 
45Caz+ release. At  3 X loF7 M Ca2+,  the 45CaZ+ efflux rate was 
half-maximally  accelerated by 1-2 mM AMP-PCP  (not 
shown). 
Mg2+ affected the channel in an opposite manner. Ca2+ 
[Co'*]od (MI 
FIG. 8. Dependence of 4aCaz' efflux on external Ca2+ con- 
centration. Cardiac SR vesicles were passively loaded with 1 mM 
45Ca2+. Ca2+ efflux rates from the Ca2+-permeable vesicle fraction were 
determined as indicated in the legend to Fig. 1. Vesicles were diluted 
into media containing the indicated  concentrations of free Ca2+ (0) 
and 5 mM AMP-PCP (V), 3 mM M e  (A) or 8 mM M%+ plus 5 mM 
AMP-PCP (0). In the presence of 5 mM free AMP-PCP (i.e. in the 
absence of M P ) ,  free Ca2+  concentrations higher than 2 X 1O"j M 
were not  tested due to complexation of Ca2+ by the nucleotide. 
release rates in the micromolar Ca2+  concentration range were 
greatly reduced by 3 mM Mg2+, and millimolar free Ca2+ 
concentrations were required to  activate  the  channel (Fig. 8). 
The  addition of 8 mM M$+ and 5 mM AMP-PCP (3 mM 
free  Mg2+) to  the Ca2+  release media shifted  the Ca2+ activa- 
tion curve to higher Ca" concentrations, similarly as observed 
for 3 mM Mg2+ alone (Fig. 8). An important difference was, 
however, that  the  channel could be nearly fully activated  in 
the presence of nucleotide and Mgz+ by raising  the  external 
Ca2+ concentration  to 1 mM. 
45Ca2+ Release in Actively Loaded Vesicles-Dependence of 
the release  behavior of cardiac vesicles on free  Ca2+  concen- 
tration was also  studied using actively loaded vesicles (Fig. 
9). Vesicles were actively filled with 45Ca2+ in media contain- 
ing 8 mM M$+, 5 mM ATP,  and varying concentrations of 
free Ca'+. The  amounts of 45Ca2+  sequestered in  the loading 
medium by vesicles containing  and lacking the Ca2+  release 
channel were determined using conditions  similar  to  those of
Fig. 1. Actively loaded vesicles were placed on Millipore filters 
and  rinsed for 10 s with  a  medium which either  inhibited (10 
mM M8+,  0.1 M EGTA, 10 p~ ruthenium  red) or activated 
(10 p~ free Caz+)  the  channel.  The difference in 45Ca2+ re- 
tained by vesicles under the two washing conditions was 
defined as  the  amount of 45Ca2+ taken  up by the Ca2+-perme- 
able vesicle population. 
Cardiac vesicles which were rinsed  with  the  10 mM M e ,  
10 p~ ruthenium red medium retained between 30 and 35 
nmol of 45Ca2+/mg of protein  after loading  for 10-20 min at  5 
X M free  Ca2+ (Fig. 9A). In  agreement with  previous 
studies  (31), a  decrease in  the free  Ca2+ concentration of the 
loading  medium to 0.3 and 0.1 p~ lowered the  initial  uptake 
rate  and  the  amount of 45Ca2+ that was sequestered by the 
vesicles within 10-20 min. In contrast, Fig. 9B gives the 
fraction of sequestered 45Ca2+ that was released when vesicles 
were rinsed  for 10 s with  the  channel  activating  rinse m dium 
(10 p~ Ca2+). Although  a change  in  the composition of the 
rinse medium was without appreciable effect when vesicles 
were actively  loaded in  the presence of 50 pM Ca2+, an  increas- 
ing  fraction of the sequestered 45Ca2+ was  released  when the 
free Ca2+ concentration in the 45Ca2+ uptake medium was 
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FrG. 9. 4aCa2+ uptake and release by cardiac vesicles. A, 
cardiac SR vesicles (Fraction IV of Table I) were  actively  loaded  as 
described under "Experimental Procedures" in media containing 8 
mM M$+, 5 mM ATP, and the indicated  concentrations of free ea2+. 
After 0.5-20 min, vesicles  were  placed on 0.45-p Millipore  filters  and 
rinsed 10 s with medium containing 10 mM M P ,  0.1 mM EGTA, and 
10 pM ruthenium  red. The amount of '%a2+  retained by the vesicles 
on the filters  is given. B, conditions  are the same as A except that 
vesicles  were  rinsed 10 s with 10 p~ Caz+ medium instead of with the 
Mg+/rutheniurn red  medium. The  fraction of %az+ that was  released 
during  rinsing  with the 10 p~ Ca2+ medium  is  shown. 
lowered from about 1 to 0.1 pM. About  one-half of the seques- 
tered 45Ca2+ was released from vesicles that were actively 
loaded at  0.3 and 0.1 p~ Ca". 
The specificity of 45Ca" uptake  and release was assessed 
by actively  loading vesicles in  the  presence of 0.1 M NaCl  and 
by preincubation with 1 FM ryanodine. In  the presence of 0.1 
M NaC1, 45Ca2+ uptake by sarcolemmal vesicles is minimal 
due to  the  immediate r lease of any  accumulated Ca2+ through 
the Na+/Ca2+ exchange system (32). In the experiments of 
Fig. 9, substitution of 0.1 M KC1 by 0.1 M NaCl did not 
significantly  reduce the  amount of 45Ca2' retained by vesicles 
loaded in  the presence of  0.3 FM free Ca2+  and  rinsed  with  the 
channel  inhibiting medium,  suggesting that 45Ca2+ uptake by 
contaminating sarcolemmal vesicles was negligible. Low con- 
centrations of ryanodine "open" the cardiac Ca2+  release 
channel  and  thereby  render passively loaded vesicles perme- 
able  to  Ca2+  in Ca2+  release channel  activating  and  inhibiting 
media  (22). In actively  loaded vesicles, preincubation  with 1 
PM ryanodine for 5 min at  37 "C reduced 1.5-%fold the 
amount of 4sCa2+ that  was  retained by vesicles loaded at  0.3 
p~ free  Ca2+ and  rinsed  with  the  channel  inhibiting medium. 
Only  a small  fraction of the  sequestered 45Ca2+ was released 
when ryanodine-treated vesicles were rinsed with channel 
activating medium,  suggesting that  ryanodine  rendered Ca2+ 
release channel  containing vesicles permeable to 45Ca2+. Pos- 
sible Ca2+  uptake by contaminating  mitochondria was blocked 
by actively  loading vesicles in the presence of 5 mM NaN3, an 
inhibitor of the  mitochondrial  electron  transport  chain,  and 
carbamyl  cyanide N-chlorophenylhydrazine, a potent  inhibi- 
tor of oxidative phosphorylation. 
Data  obtained with  actively and passively  loaded vesicles 
are in good general  agreement.  At free Ca2+ concentrations of 
1 PM and more, Ca2+ release vesicles are incapable of seques- 
tering significant amounts of 45Ca2+, because the  cardiac  Ca2+ 
release channel is sufficiently activated to cause the rapid 
release of the  transported 45Ca2+. On the  other  hand, because 
of channel  inactivation,  the Ca2+ transport  rate exceeds the 
release rate at submicromolar Ca2+ concentrations in the 
presence of Mg2+ and nucleotide,  with the result that signifi- 
cant  amounts of the  transported 45Ca2+ are  retained by Ca2+ 
release vesicles. 
DISCUSSION 
Results  presented here show that a  subpopulation of canine 
cardiac SR vesicles contains a  ligand-gated  Ca2+ release chan- 
nel that mediates the rapid release of intravesicular Ca2+ 
stores from passively loaded vesicles. At least two lines of 
evidence suggest that  the  channel  is localized in sarcoplasmic 
reticulum as opposed to another cellular structure. First, 
passively loaded "release" vesicles from cardiac membranes 
demonstrated 45Ca2+ release  behavior similar to vesicles ac- 
tively loaded via the SR Ca2+ pump. Second, Ca2+ release 
from cardiac vesicles qualitatively resembled Ca2+ release 
from heavy skeletal muscle SR vesicles. Both  channels were 
activated by external Caz+ and  adenine nucleotide and  inhib- 
ited by Mg" and calmodulin. Another argument strongly 
favoring  localization of the  Ca2+  channel  in  the  SR  membrane 
is that Ca2+ release from skeletal and cardiac SR vesicle 
fractions used in  this  study was similarly  affected  by the  plant 
alkaloid  ryanodine (22). 
Ca2+-induced calcium release from passively and actively 
loaded cardiac vesicles has been previously observed. 45Ca2+ 
efflux was stimulated a t  micromolar Ca2+  and was sensitive 
to  inhibition by ruthenium red (33-35). However, the release 
rates  reported were several orders of magnitude slower than 
those observed in the  present study. In a preliminary  report, 
Ca2+ release  peaked at  0.2 and 1 pM external  Ca2+, suggesting 
the possible involvement of two components  in  the regulation 
of the cardiac Ca2+ release channel  (36).  The presence of a 
specific Ca2+  permeability  mechanism  in a subpopulation of 
cardiac  SR vesicles has also been suggested in studies with 
the  plant alkaloid  ryanodine (20-22, 35, 37-40). Th'  1s com- 
pound profoundly alters  the Ca2+ uptake  and release proper- 
ties of isolated cardiac  and  skeletal  SR vesicle fractions by 
specifically binding  to  the Ca" release channels. 
Cardiac SR Ca2+  release vesicle fractions used in this  study 
were prepared according to a protocol  similar to  the  one used 
for the isolation of heavy SR junctional derived  Ca2+  release 
vesicles from rabbit  skeletal muscle (13). Canine ventricular 
tissue was homogenized in buffered 0.3 M sucrose solution 
and a Ca2+  release vesicle fraction was isolated in  the presence 
of the  protease  inhibitor diisopropyl fluorophosphate by  dif- 
ferential  and sucrose gradient  centrifugation. Between 40 and 
65% of the vesicular 45Ca2+ could be rapidly  released  from the 
30-40% sucrose gradient fractions, as compared to 70-90% 
from heavy skeletal muscle SR vesicles. ['HH]Ryanodine bind- 
ing  measurements  indicated a similar  number of specific high- 
affinity binding  sites (7-14 pmol/mg protein)  as  reported for 
skeletal  SR  junctional derived vesicles (4-20 pmol/mg protein; 
Refs. 20 and 21). In  contrast,  Pessah et al. (20) obtained only 
0.5 pmol of high-affinity binding  sites/mg of protein using  a 
purified cardiac  SR  preparation. 
Ca2+ release behavior of skeletal muscle SR vesicles has 
been  extensively studied using rapid flow and  rapid quench 
techniques (11, 12, 14-16), while comparable  detailed studies 
with cardiac SR vesicle fractions have not been previously 
reported  to our knowledge. The  nonlinear 45Ca2+ efflux curves 
on  the semilog plots of this  study indicate that Ca2+  release 
from cardiac vesicles is more  difficult to  evaluate by kinetic 
analysis  than  that from skeletal  Ca2+ release vesicle fractions. 
The latter display a higher Ca2+ release activity and more 
importantly, appear to be made up of a fairly homogenous 
population of vesicles (41), with the result that 45Ca2+ efflux 
3072 Ca2+ Release by Cardiac  Sarcoplasmic  Reticulum 
can be reasonably well fitted by  a single exponential  function 
and  thus  approximated by first-order kinetics. Data of the 
present  study nevertheless  show that,  in a qualitative  manner, 
the cardiac and skeletal channels are similarly affected by 
Ca2+, Mg", H', adenine nucleotide, and calmodulin. In  both 
systems, regulation of the  channel  can be  summarized by the 
equation shown below. 
Ca2+ + ATP 
"closed (f "open" 
H , Mp2+ 
[Mg. ATP, calrnodulin] 
The cardiac and  skeletal  channels  are opened  for intermittent 
times  in  the presence of micromolar  calcium and millimolar 
adenine nucleotide. The presence of both ligands is required 
to keep the two channels  open essentially  all the  time (6, 17). 
The  equation also depicts M$+ and  H+  as  inhibitors of the 
channel. 
In muscle, regulation of the  channel is more complex than 
indicated by the above equation  in  that  channel behavior is 
modulated by Mg-ATP  and calmodulin (enclosed in box). 
Most of the  ATP  in muscle is  present in the form of a Mg. 
ATP complex which modulates  the  Ca2+ dependence of 45Ca2+ 
release by skeletal (15) and cardiac (Fig. 8) SR vesicles. 
Furthermore,  the  rate of Ca2+ release  from the  Ca2+-permeable 
subpopulation of skeletal (16) and cardiac (Fig. 6) SR vesicles 
is decreased by a factor of 2-6 by exogeneously added calmod- 
ulin. Inhibition occurred in  the absence of added ATP and 
therefore does not  appear  to involve a calmodulin-dependent 
phosphorylation reaction. Instead experiments with rabbit 
skeletal muscle SR vesicles have suggested that calmodulin 
slows down 45Ca2+  release by directly interacting  in a rapid, 
reversible, Ca2+-dependent  manner with the  channel  (16).  The 
physiological function of calmodulin in  excitation-contraction 
is difficult to define at  present. One  proposal is that calmod- 
ulin, by partially  inhibiting release of Ca2+  from SR,  compen- 
sates for possible increases in  the  resting  Ca2+ level during 
increased muscle activity. 
Several important differences exist in the  extent  to which 
the cardiac and  skeletal  channels  are  activated by Ca2+ and 
adenine nucleotide and  inhibited by Mg". Micromolar con- 
centrations of Ca2+ stimulate cardiac 45Ca2+ release in the 
absence of Mg2+ and nucleotide to  as much as 50% of the 
optimal  rate, whereas  only 1-3% of the  optimal  rate could be 
achieved  in skeletal vesicles in  the absence of nucleotide and 
Mg2+ (15). A  similar  discrepancy in  the  rates of 45Ca2+ release 
was observed for vesicles diluted  into low Ca2+  media contain- 
ing  10 mM caffeine (Table 111). In  contrast,  adenine nucleo- 
tides were more effective in  stimulating 45Ca2+ release from 
skeletal  than from cardiac vesicles. This difference in effec- 
tiveness was particularly  apparent a t  low Ca2+ concentrations. 
At IOu9 M Ca", ATP was minimally effective in activating 
the cardiac channel. By comparison, in  skeletal muscle, 5 mM 
ATP was effective in  stimulating 45Ca2+ release at  lo-' M Ca2+ 
to as much as  15% of the  optimal  rate  (Table 111). Another 
significant  difference is  that 45Ca2+ efflux from cardiac vesicles 
is less sensitive to Mg2+ inhibition than that from skeletal 
vesicles. Thus, in the presence of nucleotide, it was possible 
to observe at  high concentrations of inhibitory Mg2+ (3 mM), 
vesicular 45Ca2+ release rates which would appear  to be  signif- 
icant to excitation-contraction coupling (Fig. 8). In  order  to 
observe  similarly  rapid  release rates from skeletal vesicles, it 
was necessary to decrease the free  Mg2+ concentration  in  the 
presence of nucleotide to 5 X M or lower (15). 
A  Ca2+ concentration of 1 mM and higher was required to 
optimally activate the cardiac Ca2+ release channel in the 
presence of adenine nucleotide and Mg2+ (Fig. 8). This  Ca2+ 
concentration  is 2-3 orders of magnitude  higher than  the free 
Ca2+ concentration measured in  contracting muscle (42),  thus 
raising the question of whether cardiac SR in muscle is 
capable of rapid Ca2+-induced  Ca2+  release in  the presence of 
physiological concentrations of nucleotide and M P .  It  can 
be argued, however, that Ca2+ concentrations in excess of 
measured values may exist in the junctional area during 
surface membrane Ca2+ channel  activation, considering that 
extracellular Ca" is 1-2 mM. In  this regard it is of interest 
that  recent sucrose gradient  centrifugation  studies  with vesi- 
cle fractions have suggested co-migration of the dihydropyri- 
dine labeled cardiac  surface membrane  channel  and  the  SR 
junctional  feet (43). This would suggest that, as in  skeletal 
muscle (3, 21, 35, 41),  surface membrane  and  SR Ca2+ chan- 
nels are  in close proximity. 
It  has been  proposed that physiological release of Ca2+ from 
sarcoplasmic  reticulum is induced by a second  messenger such 
as Ca2+ (3,5)  or  inositol  1,4,5-triphosphate (25-27), "depolar- 
ization" of the SR membrane (3), changes in membrane 
surface  charge (44, 45), or a pH  gradient (46). Among these 
various putative effectors we have found Ca2+ to cause the 
most dramatic  changes  in  the Ca2+  release  behavior of cardiac 
SR vesicle fractions. In our bilayer (17) and vesicle flux 
experiments, we have been unable  to  demonstrate  activation 
of the  cardiac SR Ca2+  channel by inositol 1,4,5-triphosphate. 
Also, the  cardiac  channel displays only a weak voltage de- 
pendence in  planar lipid  bilayers (17).  Furthermore,  changes 
in  membrane surface  charge, brought  about by the  addition 
to  nanomolar Ca2+  release  medium of 20 PM tetraphenylbo- 
ron- or tetraphenylarsonium+  (45), did not  stimulate 45Ca2+ 
release by more than a factor of five.3 A similar result was 
seen upon  the  creation of a pH  gradient,  brought  about by 
diluting vesicles from pH 6.5 to 7.5 and from pH 7.5 to 6.5. 
On  the  other  hand, a  raise of external  Ca2+ from lo-' to 
M Ca2+ increased the  rate of 45Ca2+  release  from  cardiac SR 
vesicles by a factor of 1000 (Table 111, Fig. 8). 
The  cardiac  and  skeletal  Ca2+  channels display a similar 
dependence on Ca", peaking a t  micromolar external free  Ca2+ 
in  the absence of Mg2+ and  adenine nucleotide. Addition of 
adenine nucleotide and Mg2+ shifts the Ca2+ concentration 
required  for  maximal  Ca2+  release  from about 2-20 WM Ca2+ 
to  about 100-1000 PM (Fig. 8, Ref. 15). Also, in  the skeletal 
system,  the  Hill  plot n value of CaZ+ activation increases  from 
1 to 2 in the presence of adenine nucleotide and Mg2+. A 
consequence of this increase in cooperativity is that  the  skel- 
etal  channel  is  rendered  sensitive  to  external  Ca2+  in a quite 
narrow  concentration range of about  to loe4 M (15). 
Similarly, 45Ca2+ release from cardiac vesicles could be nearly 
fully inhibited or activated in the presence of  M$+ and 
adenine nucleotide by varying the  external Ca2+ concentration 
from about 10"j to M (Fig. 8). One important conclusion 
that  can be drawn from these  data  is  that  under ionic condi- 
tions resembling those  in muscle, Le. in the presence of  M$+ 
and nucleotide, the cardiac channel, like the  skeletal  channel, 
displays a strict dependence on Ca2+. In comparison, ATP 
and M$+ may play a more limited role in regulating Ca2+ 
release; our  data suggest that  ATP  and Mg2+ act  as allosteric 
effectors of the  channel by modulating the channel's sensitiv- 
ity  to  external Ca2+. This  interpretation is supported by the 
fact  that,  in  contrast to Ca", the  concentrations of M e  and 
nucleotide are thought to remain fairly constant during all 
phases of muscle activity. 
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